Zenotech Laboratories Limited

BSE: 532039
Zenotech Laboratories Limited - pharma in Hyd, Telangana, India. FY 2026 financials and compliance.
CIN L27100TG1989PLC010122 Incorporated 15 June 1989 ROC Hyderabad HQ Hyd, Telangana, India
Active Listed - BSE: 532039 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹39.56 Cr
▲ 1.5% YoY
Computed EBITDA · FY 2026
₹11.5 Cr
▼ 26.9% YoY
Net profit · FY 2026
-₹1.07 Cr
▼ 119.1% YoY
Authorised capital
₹100 Cr
Registered with MCA
Paid-up capital
₹61.03 Cr
Issued & subscribed
Open charges
₹6 Cr
Satisfied ₹64.71 Cr
Company age
37 yrs
Est. 1989
Employees · EPFO
181
Latest available

About Zenotech Laboratories Limited

Data last updated: 14 July 2026

Zenotech Laboratories Limited is a public limited company based in Hyd, Telangana, India, a subsidiary of Sun Pharmaceutical Industries Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 15 June 1989, the company has been in operation for over 37 years.

Registered with ROC Hyderabad under CIN L27100TG1989PLC010122. Listed on BSE: 532039.

Capital: an authorised share capital of ₹100 Cr and a paid-up capital of ₹61.03 Cr. It is led by directors including Azadar Husain Asghar Mehdi Khan and Jignesh Anantray Goradia.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyd, Telangana.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹39.56 Cr, a growth of 1.5% compared to the previous year. The net worth stands at ₹95.12 Cr (down 1.05% YoY). Total assets are valued at ₹111.15 Cr (up 0.11% YoY).

The company has a workforce of approximately 181 employees as per the latest available data. It operates as a subsidiary of Sun Pharmaceutical Industries Limited.

The company is associated with 1 brand - Zenotech Laboratories. As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹64.71 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zenotechlab.com.

Company Details of Zenotech Laboratories Limited
CIN L27100TG1989PLC010122
Registration Number 010122
Incorporation Date 15 June 1989
ROC Hyderabad
Listing Status Listed (BSE: 532039)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Sun Pharmaceutical Industries Limited
Compliance Status Active Compliant
Key People
Azadar Husain Asghar Mehdi Khan Director Jignesh Anantray Goradia Director Jagruti Prashant Sheth Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    zenotechlab.com
  • Social Media
  • Registered Address
    Survey No.250 – 252 Turkapally Village Genome Valley Road, Shamirpet Mandal Medchal – Malkajgiri District, Hyd, Telangana, India – 500101
  • Industry
    Pharma, Drug Formulation & Development
Company report
Zenotech Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Zenotech Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Zenotech Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Zenotech Laboratories Limited

Zenotech Laboratories Limited has one previous CIN (Corporate Identification Number): L27100AP1989PLC010122. The current CIN is L27100TG1989PLC010122, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L27100TG1989PLC010122 Current
L27100AP1989PLC010122 Previous

Associated Brands with Zenotech Laboratories Limited

Zenotech Laboratories Limited operates one associated brand: Zenotech Laboratories. These brands represent Zenotech Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Zenotech Laboratories
Generic injectables for oncology and anesthesiology are manufactured. zenotechlab.com

Business Activity of Zenotech Laboratories Limited

Zenotech Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Zenotech Laboratories Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Zenotech Laboratories Limited

Zenotech Laboratories Limited is audited by G S K A & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
G S K A & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Zenotech Laboratories Limited

Zenotech Laboratories Limited is currently managed by 6 directors, with 37 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Azadar Husain Asghar Mehdi Khan
Also directs: Nimbua Greenfield (Punjab) Association, Foundation For Disease Elimination And Control Of India
Director 25 Aug 2015 10 Years 11 Months Current
Jignesh Anantray Goradia Director 08 Jul 2015 11 Years 1 Months Current
Jagruti Prashant Sheth
Also directs: Monika Alcobev Limited
Director 01 Feb 2020 6 Years 6 Months Current
Rakeshchandra Jagdishprasad Sinha
Also directs: Caraco Pharmaceuticals Private Limited, Sun Pharma Laboratories Limited, Neetnav Real Estate Private Limited and 4 more
Director 01 Feb 2020 6 Years 6 Months Current
Premal Hemant Gandhi
Also directs: Dheevit Consultant Private Limited, Keshava Foundation For Educare
Director 28 Jan 2025 1 Years 6 Months Current
Nikkhil Venilal Kothhari Director 23 Jan 2026 0 Years 6 Months Current
View all directors

Financials of Zenotech Laboratories Limited FY 2026 filings available

Zenotech Laboratories Limited reported revenue of ₹39.56 Cr (up 1.5% YoY) for FY 2026.

Revenue · FY 2026
₹39.56 Cr ▲ 1.5%
Profit · FY 2026
-₹1.07 Cr ▼ 119.1%
Computed EBITDA · FY 2026
₹11.5 Cr ▼ 26.9%
Revenue₹ Cr · Standalone02040FY 2019: ₹13 Cr13FY 2019FY 2020: ₹26 Cr · +99.1% YoY25.9+99.1%FY 2020FY 2021: ₹22 Cr · -13.5% YoY22.4-13.5%FY 2021FY 2022: ₹37 Cr · +62.9% YoY36.6+62.9%FY 2022FY 2023: ₹38 Cr · +4.9% YoY38.4+4.9%FY 2023FY 2024: ₹37 Cr · -4.1% YoY36.8-4.1%FY 2024FY 2025: ₹39 Cr · +6% YoY39+6%FY 2025FY 2026: ₹40 Cr · +1.5% YoY39.6+1.5%FY 2026
Net Profit₹ Cr · Standalone-100102030FY 2019: ₹3 Cr (loss)-3.1FY 2019FY 2020: ₹11 Cr · +444.6% YoY10.8+444.6%FY 2020FY 2021: ₹1 Cr (loss) · -111.3% YoY-1.2FY 2021FY 2022: ₹22 Cr · +1925% YoY22.2+1925%FY 2022FY 2023: ₹12 Cr · -47.8% YoY11.6-47.8%FY 2023FY 2024: ₹8 Cr · -28.3% YoY8.3-28.3%FY 2024FY 2025: ₹6 Cr · -32.5% YoY5.6-32.5%FY 2025FY 2026: ₹1 Cr (loss) · -119.1% YoY-1.1FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year051015Q1'25: ₹10 Cr9.9Q1'25Q2'25: ₹9 Cr8.7Q2'25Q3'25: ₹10 Cr10.2Q3'25Q4'25: ₹11 Cr11.1Q4'25Q1'26: ₹9 Cr · -12.8% YoY8.6-12.8%Q1'26Q2'26: ₹10 Cr · +17% YoY10.2+17%Q2'26Q3'26: ₹12 Cr · +15.7% YoY11.8+15.7%Q3'26Q4'26: ₹9 Cr · -20.2% YoY8.9-20.2%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹39.56 Cr ₹38.98 Cr ₹36.76 Cr ₹38.35 Cr ₹36.57 Cr ₹22.45 Cr ₹25.94 Cr ₹13.03 Cr
Other Income ₹6.36 Cr ₹5.62 Cr ₹5.08 Cr ₹5.16 Cr ₹62.93 Lakh ₹40.84 Lakh ₹1.25 Cr ₹4.71 Cr
Total Income ₹45.92 Cr ₹44.6 Cr ₹41.84 Cr ₹43.51 Cr ₹37.19 Cr ₹22.85 Cr ₹27.19 Cr ₹17.74 Cr
Cost of Materials Consumed ₹0 ₹84.02 Lakh ₹0 ₹6.08 Lakh ₹11,000 ₹3.22 Lakh ₹50.45 Lakh ₹70.55 Lakh
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹1.19 Lakh
Employee Benefit Expense ₹15.53 Cr ₹12.38 Cr ₹9.46 Cr ₹7.88 Cr ₹7.1 Cr ₹6.49 Cr ₹5.76 Cr ₹4.98 Cr
Finance Costs ₹0 ₹0 ₹0 ₹11.22 Lakh ₹1.22 Cr ₹1.55 Cr ₹89.25 Lakh ₹11.77 Lakh
Depreciation & Amortisation ₹7.11 Cr ₹6.96 Cr ₹7.09 Cr ₹7.17 Cr ₹6.97 Cr ₹6.46 Cr ₹4.85 Cr ₹4.2 Cr
Other Expenses ₹18.9 Cr ₹15.65 Cr ₹14.15 Cr ₹13.78 Cr ₹12.01 Cr ₹9.54 Cr ₹10.77 Cr ₹10.85 Cr
Total Expenses ₹41.54 Cr ₹35.83 Cr ₹30.7 Cr ₹29.01 Cr ₹27.29 Cr ₹24.07 Cr ₹22.78 Cr ₹20.87 Cr
Profit Before Exceptional Items & Tax ₹4.38 Cr ₹8.77 Cr ₹11.14 Cr ₹14.5 Cr ₹9.9 Cr -₹1.22 Cr ₹4.41 Cr -₹3.13 Cr
Exceptional Items -₹19.51 Lakh ₹1.92 Cr ₹0 ₹0 ₹0 ₹0 ₹6.37 Cr ₹0
Profit Before Tax ₹4.19 Cr ₹10.69 Cr ₹11.14 Cr ₹14.5 Cr ₹9.9 Cr -₹1.22 Cr ₹10.78 Cr -₹3.13 Cr
Total Tax Expense ₹5.26 Cr ₹5.08 Cr ₹2.83 Cr ₹2.92 Cr -₹12.27 Cr ₹0 ₹0 ₹0
Net Profit -₹1.07 Cr ₹5.61 Cr ₹8.31 Cr ₹11.59 Cr ₹22.18 Cr -₹1.22 Cr ₹10.78 Cr -₹3.13 Cr
Other Comprehensive Income ₹4.67 Lakh -₹1.68 Lakh -₹3.84 Lakh ₹3.35 Lakh ₹5.6 Lakh -₹57,000 -₹4.68 Lakh ₹77,000
Total Comprehensive Income -₹1.03 Cr ₹5.6 Cr ₹8.27 Cr ₹11.62 Cr ₹22.23 Cr -₹1.22 Cr ₹10.73 Cr -₹3.12 Cr
EBITDA (computed) ₹11.5 Cr ₹15.73 Cr ₹18.23 Cr ₹21.79 Cr ₹18.09 Cr ₹6.79 Cr ₹10.15 Cr ₹1.19 Cr
Basic EPS ₹-0.18 ₹0.92 ₹1.36 ₹1.90 ₹3.63 ₹-0.20 ₹1.77 ₹-0.51
Diluted EPS ₹-0.18 ₹0.00 ₹1.36 ₹1.90 ₹3.63 ₹-0.20 ₹1.77 ₹-0.51
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹111.15 Cr ₹111.03 Cr ₹106.21 Cr ₹100.87 Cr ₹94.08 Cr ₹85.84 Cr ₹85.55 Cr ₹84.58 Cr
Non-current Assets ₹70.11 Cr ₹75.04 Cr ₹80.04 Cr ₹84.61 Cr ₹86.71 Cr ₹78.5 Cr ₹79.85 Cr ₹65.39 Cr
Current Assets ₹41.04 Cr ₹35.99 Cr ₹26.16 Cr ₹16.26 Cr ₹7.37 Cr ₹7.35 Cr ₹5.71 Cr ₹19.19 Cr
Property, Plant & Equipment ₹62.29 Cr ₹60.87 Cr ₹65.58 Cr ₹65.38 Cr ₹70.91 Cr ₹74.23 Cr ₹48.73 Cr ₹43.11 Cr
Inventories ₹0 ₹0 ₹84.02 Lakh ₹0 ₹6.08 Lakh ₹6.19 Lakh ₹9.41 Lakh ₹58.42 Lakh
Trade Receivables ₹8.78 Cr ₹7.45 Cr ₹3.25 Cr ₹3.32 Cr ₹3.93 Cr ₹3.8 Cr ₹1.86 Cr ₹2.36 Cr
Cash & Equivalents ₹30.29 Cr ₹26.58 Cr ₹1.82 Cr ₹11.14 Cr ₹2.41 Cr ₹2.46 Cr ₹1.08 Cr ₹13.2 Cr
Equity (Net Worth) ₹95.12 Cr ₹96.13 Cr ₹90.54 Cr ₹82.27 Cr ₹70.64 Cr ₹48.41 Cr ₹49.63 Cr ₹38.9 Cr
Equity Share Capital ₹61.03 Cr ₹61.03 Cr ₹61.03 Cr ₹61.03 Cr ₹61.03 Cr ₹61.03 Cr ₹61.03 Cr ₹61.03 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹6 Cr ₹20.66 Cr ₹0 ₹0
Borrowings (Current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹18.66 Cr ₹20.24 Cr
Total Debt (computed) ₹0 ₹0 ₹0 ₹0 ₹6 Cr ₹20.66 Cr ₹18.66 Cr ₹20.24 Cr
Current Liabilities ₹12.06 Cr ₹12.59 Cr ₹13.52 Cr ₹16.61 Cr ₹15.58 Cr ₹14.95 Cr ₹35.44 Cr ₹45.35 Cr
Total Liabilities ₹16.03 Cr ₹14.9 Cr ₹15.66 Cr ₹18.6 Cr ₹23.44 Cr ₹37.44 Cr ₹35.93 Cr ₹45.69 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹10.2 Cr ₹9.45 Cr ₹11.83 Cr ₹20.66 Cr ₹17.66 Cr
Investing Cash Flow -₹6.49 Cr ₹15.29 Cr -₹21.15 Cr -₹5.82 Cr -₹1.84 Cr
Financing Cash Flow ₹0 ₹0 ₹0 -₹6.11 Cr -₹15.87 Cr
Capital Expenditure ₹8.32 Cr ₹3.86 Cr ₹4.23 Cr ₹6.23 Cr ₹1.94 Cr
Free Cash Flow (computed) ₹1.88 Cr ₹5.59 Cr ₹7.6 Cr ₹14.43 Cr ₹15.73 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹3.71 Cr ₹24.76 Cr -₹9.33 Cr ₹8.73 Cr -₹4.29 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹8.87 Cr ₹11.83 Cr ₹10.23 Cr ₹8.64 Cr ₹11.11 Cr ₹10.22 Cr ₹8.75 Cr ₹9.91 Cr
Other Income ₹1.61 Cr ₹1.45 Cr ₹1.7 Cr ₹1.59 Cr ₹1.51 Cr ₹1.39 Cr ₹1.36 Cr ₹33.7 Lakh
Total Income ₹10.48 Cr ₹13.28 Cr ₹11.94 Cr ₹10.23 Cr ₹12.62 Cr ₹11.61 Cr ₹10.11 Cr ₹10.25 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹42.75 Lakh ₹20.25 Lakh ₹13.91 Lakh ₹7.11 Lakh
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹4.17 Cr ₹4.02 Cr ₹3.8 Cr ₹3.54 Cr ₹3.23 Cr ₹3.18 Cr ₹3.01 Cr ₹2.95 Cr
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹1.76 Cr ₹1.8 Cr ₹1.78 Cr ₹1.77 Cr ₹1.73 Cr ₹1.76 Cr ₹1.75 Cr ₹1.73 Cr
Other Expenses ₹5.54 Cr ₹4.57 Cr ₹5.14 Cr ₹3.65 Cr ₹4 Cr ₹3.99 Cr ₹4.21 Cr ₹3.45 Cr
Total Expenses ₹11.47 Cr ₹10.39 Cr ₹10.73 Cr ₹8.95 Cr ₹9.39 Cr ₹9.13 Cr ₹9.11 Cr ₹8.2 Cr
Profit Before Exceptional Items & Tax -₹98.96 Lakh ₹2.89 Cr ₹1.21 Cr ₹1.28 Cr ₹3.24 Cr ₹2.49 Cr ₹1 Cr ₹2.05 Cr
Exceptional Items ₹5.41 Lakh -₹29.89 Lakh ₹4.97 Lakh ₹0 -₹4.88 Lakh ₹62.4 Lakh ₹1.35 Cr ₹0
Profit Before Tax -₹93.55 Lakh ₹2.59 Cr ₹1.26 Cr ₹1.28 Cr ₹3.19 Cr ₹3.11 Cr ₹2.35 Cr ₹2.05 Cr
Total Tax Expense ₹2.22 Cr ₹66.38 Lakh ₹2.09 Cr ₹28.72 Lakh ₹1.96 Cr ₹1.42 Cr ₹1 Cr ₹75.58 Lakh
Net Profit -₹3.15 Cr ₹1.93 Cr -₹83.65 Lakh ₹98.96 Lakh ₹1.23 Cr ₹1.69 Cr ₹1.35 Cr ₹1.29 Cr
Other Comprehensive Income ₹6 Lakh -₹44,000 -₹46,000 -₹42,000 ₹36,000 -₹68,000 -₹68,000 -₹68,000
Total Comprehensive Income -₹3.09 Cr ₹1.92 Cr -₹84.11 Lakh ₹98.54 Lakh ₹1.23 Cr ₹1.69 Cr ₹1.34 Cr ₹1.28 Cr
EBITDA (computed) ₹76.84 Lakh ₹4.69 Cr ₹2.99 Cr ₹3.05 Cr ₹4.96 Cr ₹4.25 Cr ₹2.75 Cr ₹3.77 Cr
Basic EPS ₹-0.52 ₹0.32 ₹0.14 ₹0.16 ₹0.20 ₹0.28 ₹0.22 ₹0.21
Diluted EPS ₹-0.52 ₹0.32 ₹0.14 ₹0.16 ₹0.00 ₹0.28 ₹0.22 ₹0.21
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Zenotech Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Zenotech Laboratories Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 68.84%, domestic institutional investors hold 0.01%, retail and other public shareholders hold 30.17% of Zenotech Laboratories Limited. The company had 10,301 shareholders on record.

Promoters: 68.84%DII (Domestic Institutional): 0.01%Retail & Others: 30.17%Others: 0.98%
Mar 2026
QUARTER
68.84% Promoters
0.01% DII (Domestic Institutional)
30.17% Retail & Others
0.98% Others
Promoter holding - history
Now 68.84% · Mar 2026High 68.84% · Jun 2023Low 68.84% · Jun 2023
67%67.8%68.5%69.3%70%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 68.84%Sep 2023: 68.84%Dec 2023: 68.84%Mar 2024: 68.84%Jun 2024: 68.84%Sep 2024: 68.84%Dec 2024: 68.84%Mar 2025: 68.84%Jun 2025: 68.84%Sep 2025: 68.84%Dec 2025: 68.84%Mar 2026: 68.84%68.84%68.84%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters68.84%68.84%68.84%68.84%68.84%68.84%
Public31.16%31.16%31.16%31.16%31.16%31.16%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters68.84%68.84%68.84%
Public31.16%31.16%31.16%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Zenotech Laboratories Limited

Open charges
₹6 Cr
Satisfied charges
₹64.71 Cr
Breakdown by lending institutions
Technology Development Board₹6.00 Cr
Latest charge details
DateLenderAmountStatus
24 Oct 2005 Technology Development Board ₹6 Cr Open
20 Mar 2012 Hdfc Bank Limited ₹15 Cr Satisfied
17 Jan 2008 Yes Bank Limited ₹10 Cr Satisfied
24 May 2006 Indian Overseas Bank ₹10 Cr Satisfied
19 Jan 2006 Andhra Bank ₹4 Cr Satisfied

Total charge records: 10 View all charges

Employees and EPFO Compliance at Zenotech Laboratories Limited

Zenotech Laboratories Limited has a workforce of 181 employees as of Apr 08, 2024.

Employee count
181
Active EPFO establishments
1
Employee growth
21.48%
Premium access

Employee and EPFO history for Zenotech Laboratories Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Zenotech Laboratories Limited

Premium access

GST registrations and filing compliance for Zenotech Laboratories Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Zenotech Laboratories Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Zenotech Laboratories Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Zenotech Laboratories Limited

Premium access

MSME payment history for Zenotech Laboratories Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Zenotech Laboratories Limited

Premium access

Corporate group structure for Zenotech Laboratories Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Zenotech Laboratories Limited

Premium access

MCA filings and documents for Zenotech Laboratories Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Zenotech Laboratories Limited

Directors
23 Jan 2026
Nikkhil Venilal Kothhari was appointed as a Director on 23 Jan 2026 & has been associated with this company since 6 months 28 days.
Activity
26 Sep 2025
Zenotech Laboratories Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Zenotech Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
28 Jan 2025
Premal Hemant Gandhi was appointed as a Director on 28 Jan 2025 & has been associated with this company since 1 year 6 months.
Directors
07 Nov 2024
Sachin Laxmanappa Gavandare was appointed as a Ceo on 07 Nov 2024 & has been associated with this company since 1 year 9 months.
Directors
01 Feb 2020
Jagruti Prashant Sheth was appointed as a Director on 01 Feb 2020 & has been associated with this company since 6 years 6 months.

Recent News on Zenotech Laboratories Limited

Frequently Asked Questions about Zenotech Laboratories Limited

Zenotech Laboratories Limited is an active public limited company in the pharma sector based in Hyd, Telangana, India. It was incorporated on 15 June 1989 (37+ years old) and is registered under CIN L27100TG1989PLC010122. Listed on BSE: 532039. The company has 181 employees.

Zenotech Laboratories Limited reported revenue of ₹39.56 Cr for FY 2026 (up 1.5% YoY) based on standalone BSE filings.

The current directors of Zenotech Laboratories Limited are:

The primary industry of Zenotech Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Zenotech Laboratories Limited is listed on BSE with code 532039.

Zenotech Laboratories Limited can be reached at the registered office: Survey No.250 – 252 Turkapally Village Genome Valley Road, Shamirpet Mandal Medchal – Malkajgiri District, Hyd, Telangana, India – 500101, or through the website zenotechlab.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available